Best of the Week
Most Popular
1. Gold vs Cash in a Financial Crisis - Richard_Mills
2.Current Stock Market Rally Similarities To 1999 - Chris_Vermeulen
3.America See You On The Dark Side Of The Moon - Part2 - James_Quinn
4.Stock Market Trend Forecast Outlook for 2020 - Nadeem_Walayat
5.Who Said Stock Market Traders and Investor are Emotional Right Now? - Chris_Vermeulen
6.Gold Upswing and Lessons from Gold Tops - P_Radomski_CFA
7.Economic Tribulation is Coming, and Here is Why - Michael_Pento
8.What to Expect in Our Next Recession/Depression? - Raymond_Matison
9.The Fed Celebrates While Americans Drown in Financial Despair - John_Mauldin
10.Hi-yo Silver Away! - Richard_Mills
Last 7 days
Predictive Modeling Suggests US Stock Markets 12% Over Valued - 27th May 20
Why Stocks Bear Market Rallies Are So Tricky - 27th May 20
Precious Metals Hit Resistance - 27th May 20
Crude Oil Cuts Get Another Saudi Boost as Oil Demand Begins to Show Signs of Life - 27th May 20
Where the Markets are heading after COVID-19? - 27th May 20
Silver Springboards Higher – What’s Next? - 26th May 20
Stock Market Key Resistance Breakout Is Where the Rubber Meets the Road - 26th May 20
5 Ways To Amp Up Your CFD Trading Today - 26th May 20
The Anatomy of a Gold Stock Bull Market - 26th May 20
Stock Market Critical Price Level Could Soon Prompt A Big Move - 25th May 20
Will Powell Decouple Gold from the Stock Market? - 25th May 20
How Muslims Celebrated EID in Lockdown Britain 2020 - UK - 25th May 20
Stock Market Topping Behavior - 24th May 20
Fed Action Accelerates Boom-Bust Cycle; Not A Virus Crisis - 23rd May 20
Gold Silver Miners and Stocks (after a quick drop) Ready to Explode - 23rd May 20
3 Ways to Prepare Financially for Retirement - 23rd May 20
4 Essential Car Trade-In Tips To Get The Best Value - 23rd May 20
Budgie Heaven at Bird Land - 23rd May 20
China’s ‘Two Sessions’ herald Rebound of Economy - 22nd May 20
Signs Of Long Term Devaluation US Real Estate - 22nd May 20
Reading the Tea Leaves of Gold’s Upcoming Move - 22nd May 20
Gold, Silver, Mining Stocks Teeter On The Brink Of A Breakout - 21st May 20
Another Bank Bailout Under Cover of a Virus - 21st May 20
Do No Credit Check Loans Online Instant Approval Options Actually Exist? - 21st May 20
An Eye-Opening Perspective: Emerging Markets and Epidemics - 21st May 20
US Housing Market Covid-19 Crisis - 21st May 20
The Coronavirus Just Hit the “Fast-Forward” Button on These Three Industries - 21st May 20
AMD Zen 3 Ryzen 9 4950x Intel Destroying 24 core 48 thread Processor? - 21st May 20
Dow Stock Market Trend Analysis and Forecast - 20th May 20
The Credit Markets Gave Their Nod to the S&P 500 Upswing - 20th May 20
Where to get proper HGH treatment in USA - 20th May 20
Silver Is Ensured A Prosperous 2020 Thanks To The Fed - 20th May 20
It’s Not Only Palladium That You Better Listen To - 20th May 20
DJIA Stock Market Technical Trend Analysis - 19th May 20
US Real Estate Showing Signs Of Covid19 Collateral Damage - 19th May 20
Gold Stocks Fundamental Indicators - 19th May 20
Why This Wave is Usually a Market Downturn's Most Wicked - 19th May 20
Gold Mining Stocks Flip from Losses to 5x Leveraged Gains! - 19th May 20
Silver Price Begins To Accelerate Higher Faster Than Gold - 19th May 20
Gold Will Soar Soon; World Now Faces 'Monetary Armageddon' - 19th May 20
Gold Mining Stocks Fundamentals - 18th May 20
Why the Largest Cyberattack in History Will Happen Within Six Months - 18th May 20
New AMD Ryzen 4900x and 4950x Zen3 4th Gen Processors Clock Speed and Cores Specs - 18th May 20
Learn How to Play the Violin, Kids Activities and Learning During Lockdown - 18th May 20
The Great Economy Reopening Gamble - 17th May 20
Powell Sends a Message With Love for Gold - 17th May 20
An Economic Renaissance Emerges – Stock Market Look Out Below - 17th May 20
Learn more about the UK Casino Self-exclusion - 17th May 20
Will Stocks Lead the Way Lower for Gold Miners? - 15th May 20
Are Small-Cap Stocks (Russell 2k) Headed For A Double Dip? - 15th May 20
Coronavirus Will Wipe Out These Three Industries for Good - 15th May 20
Gold and Silver: As We Go from Deflation to Hyperinflation - 15th May 20

Market Oracle FREE Newsletter

Category: BioTech

The analysis published under this category are as follows.

Companies

Friday, June 21, 2013

How to Double Your Money by Investing in Biotech / Companies / BioTech

By: Money_Morning

Diane Alter writes: Some of the most lucrative opportunities you can find now are in the biotechnology industry – which is why we've been working to uncover the best ways for how to invest in this sector.

The best biotech companies overflow with innovation. They can offer a steady stream of game-changing products – which often translates to record-breaking revenue.

Read full article... Read full article...

 


Companies

Thursday, June 20, 2013

How to Profit from the Supreme Court DNA Patenting Ruling / Companies / BioTech

By: Money_Morning

Tara Clarke writes: A rather complicated U.S. Supreme Court ruling in Association for Molecular Pathology v. Myriad Genetics, Inc. came out last week on whether life or more specifically DNA can be patented.

I don't want to talk about the science behind the ruling. It gets complicated. Rather, I'd like to simply breakdown how the High Court's decision can affect your wallet.

Read full article... Read full article...

 


Companies

Monday, June 17, 2013

Deadly Saudi MERS-CoV Global Pandemic Bio-tech Stocks Profit Potential / Companies / BioTech

By: Money_Morning

Greg Madison writes: One of the really beneficial things about science is its power to transcend borders and ideologies. Scientists in countries that may be totally hostile to one another have the chance of collaborating on difficult problems in a spirit of openness.

This ability to collaborate and exchange information across borders is particularly important when a new disease with global pandemic potential emerges, as it has in the Middle East with the respiratory system coronavirus (MERS-CoV).

Read full article... Read full article...

 


Companies

Tuesday, May 07, 2013

What Could Be the Most Lucrative Time Ever for Biotech Investing / Companies / BioTech

By: Money_Morning

Tim Melvin writes: Some of the most exciting developments in the last fifty years have been in the biotechnology industry - which has also meant the emergence of some of the best investments for 2013.

Just look at the progress biotech has made in medicine.

Read full article... Read full article...

 


Companies

Friday, May 03, 2013

Exciting Biotech Stocks Investing Ideas Have Explosive Potential / Companies / BioTech

By: TLSReport

In January 2013, The Life Sciences Report debuted its biotech Watchlist, which outlined ideas for investors keyed to catalysts in the drug development process that typically move biotechnology stocks. All stocks are affected by catalysts, but nowhere do they provide more leverage (or deleverage) than in biotech. We predicted the new year would present legitimate prospects for portfolio growth. So far, that has been the case. Although the party has given way to some fatigue, the punch bowl is still on the table and the biotech upswing continues.

Read full article... Read full article...

 


Companies

Wednesday, April 17, 2013

Investing in Biotech Stem Cell Research Companies / Companies / BioTech

By: TLSReport

Naysayers may harp on the low market valuations of stem cell companies, but Geoff MacKay has an insider's perspective. The Alliance for Regenerative Medicine chairman and Organogenesis Inc. president and CEO asserts that though the regenerative medicine and cell technology industry is still largely in phase 1/2, phase 3 and commercial success are imminent. In this interview with The Life Sciences Report, MacKay explains the promise of cell therapies for both patient health and investors' portfolios.

 

The Life Sciences Report: Congratulations on being elected chairman of the board of the Massachusetts Biotechnology Council (MassBio). After almost three decades, it's the nation's oldest biotech trade organization. That really speaks to the respect that your peers have for you. Could you tell me a bit about MassBio? What is it about?

Read full article... Read full article...

 


Companies

Friday, April 12, 2013

Stocks that Can Mend the Biotech Market / Companies / BioTech

By: TLSReport

Markets are not efficient—at least not in the short term. WBB Securities President Stephen Brozak admits to frustration when he sees small-cap companies with valuations that are disengaged from market realities. But Brozak's experience as a biotech investor, banker and analyst has taught him to be patient with these disconnection syndromes, and he now delights in prospects offered by select bargain-basement opportunities. In this interview with The Life Sciences Report, Brozak touches on 10 names that have been flying far below the radars of most investors.


The Life Sciences Report: Steve, you have something you'd like to get off your mind. Tell me.

Read full article... Read full article...

 


Companies

Tuesday, April 09, 2013

Biotechs Stocks with Staggering Profit Potential / Companies / BioTech

By: TLSReport

When it comes to picking biotech stocks, does a buyside perspective matter more than a sellside? Not according to Zacks Investment Research Analyst Grant Zeng, who has straddled the divide. What really matters is research of uncompromised quality. In this interview with The Life Sciences Report, Zeng offers a primer on what he looks for in a biotech investment, and names companies with the potential for big returns.

The Life Sciences Report: Grant, you've been on both the buyside and the sellside. Today you're an analyst at Zacks, a noninvestment bank firm that does not have to solicit business from the companies on which it performs due diligence and research. Is there an advantage for investors in this research model?

Read full article... Read full article...

 


Companies

Saturday, March 30, 2013

Big Growth Stories in Bio-technology Stocks Sector / Companies / BioTech

By: TLSReport

As a former biotechnology researcher and 25-year Wall Street veteran, Griffin Securities Inc. Analyst and Scientific Director Keith Markey understands how novel, cutting-edge technology can produce extraordinary new products that bring in revenues with double-digit growth potential. Markey reveals his best ideas in this Life Sciences Report interview, providing his growth thesis for every name and describing why each has potential for at least a double.

 

The Life Sciences Report: You've been an analyst for more than two decades, and before that you were a wet lab bench guy working in the realm of endocrinology and neurobiology. You came to the financial industry when biotechnology was still nascent. How has drug discovery changed over time?

Read full article... Read full article...

 


Companies

Friday, March 15, 2013

How Stock Market Investors Can Ride the Nanotech Revolution / Companies / BioTech

By: Money_Morning

G.S. Early writes: I know that for more than a few of you, as soon as you hear the word "nanotech" your eyes glaze over and you fumble for the mouse.

But don't touch that mouse. Nanotech has come a long way and is becoming one of the most incredible technology stories of the decade, if not the century.

Read full article... Read full article...

 


Companies

Friday, March 08, 2013

10 Biotech Stocks Poised to Run / Companies / BioTech

By: TLSReport

For the first time in ages, conditions for biotech investment are just right. The capital markets have loosened up, and institutional investors are ready to bid up share prices on stories that have both merit and looming catalysts. Sure, there's risk. . .but without it, there's no upside. In this Life Sciences Report interview, Senior Analyst and Managing Director George Zavoico of MLV & Co. identifies a group of biotech companies with market-moving events on their calendars. Sharpen your pencils: From cancer to coronary artery disease to vaccine technology, Zavoico names potential winners.

Read full article... Read full article...

 


Companies

Sunday, March 03, 2013

Small Companies Hubs of Future Profit in Regenerative Medicine / Companies / BioTech

By: TLSReport

 

Gil Van Bokkelen has been in the stem cell industry for more than a decade. In recent years, the co-founder, chairman and chief executive officer of Athersys Inc. has stepped into regenerative medicine’s forefront, acting as a spokesman for the industry as well as demonstrating his love of science and passionately advocating for patients. In this interview with The Life Sciences Report, Van Bokkelen explores the past, present and future of the cell therapy and regenerative medicine industry, and outlines the investment possibilities in small companies on the sector's cutting edge.

Read full article... Read full article...

 


Companies

Friday, March 01, 2013

Biotech Miracle Medical Breakthrough: Printing 3D Organs! / Companies / BioTech

By: Money_Morning

Michael A. Robinson writes: Imagine a future in which anyone needing a transplant could just create the needed tissue on their home printer.

That day hasn't arrived yet ... but it's getting closer all the time.

A partnership between a global software firm and an early-stage biotech player is already promising to transform the field of medical transplants.

Read full article... Read full article...

 


Companies

Wednesday, February 27, 2013

The Picks and Shovels of Biotech Investing / Companies / BioTech

By: Investment_U

Marc Lichtenfeld writes: Yesterday marked the 184th birthday of an iconic American businessman – Levi Strauss

My wife worked for Levi Strauss & Co. many years ago. They were a terrific company, with a strong commitment to product quality, their employees and their community. I was so impressed that I remain loyal and almost exclusively buy Levi’s when I need a pair of jeans.

Read full article... Read full article...

 


Companies

Wednesday, January 16, 2013

BioTech Bull Market's Next 1,000%-Plus Move Starts Now / Companies / BioTech

By: DailyWealth

Dr. Steve Sjuggerud writes: Biotech stocks have an incredible history of delivering quadruple-digit runs about once a decade...

It's stunning, really. In the late 1980s, biotech stocks took off, returning 3,246% in just a couple years. In the late 1990s, biotech stocks took off again, returning 1,523% in an even shorter period of time.

Read full article... Read full article...

 


Companies

Thursday, December 13, 2012

The Next Profit Breakthrough: Synthetic Biology / Companies / BioTech

By: Money_Morning

Michael A. Robinson writes: Drug, chemical, and biofuel firms are relying more than ever on artificial fragments of DNA to invent new products. It's called synthetic biology.

For example, teams all over the world are now in their labs looking to create novel biotech compounds or drugs by inserting synthetic DNA into cells, either living or artificial. They're also growing new microorganisms that yield biofuels to be used in lieu of oil.

Read full article... Read full article...

 


Companies

Tuesday, December 11, 2012

Cancer, Breaking Down a Biotech Winner / Companies / BioTech

By: Alex_Daley

Traditional cancer treatment options are little more than a crude mix of "slash, burn, and poison" â �that is surgery, radiation, and chemotherapy. There are radical new treatments in labs and trials all over the world that promise to throw out this trifecta; no other disease has received more of the research interest and funding that have defined modern biotechnology over the past three decades.

Read full article... Read full article...

 


Companies

Thursday, November 15, 2012

Biotech Stocks to Buy Now / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleDon Miller writes: If you're looking to hit a home run over the next 12 months, your best bet for stocks to buy now is biotechnology companies - especially those focused on cancer research.

Here's why: biotech stocks have been in a stealth bull market in 2012.

Read full article... Read full article...

 


Companies

Monday, October 22, 2012

Adult Stem Cells: Investors can Cash in on the New Fountain of Youth / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleMichael A. Robinson writes: It's flat-out amazing how fast the science of adult stem cells is moving.

Just last week, I told you about two scientists who won the 2012 Nobel Prize in Medicine for creating this field.

Read full article... Read full article...

 


Companies

Friday, October 19, 2012

Adult Stem Cell Miracle Will Generate Investor Profits / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleMichael A. Robinson writes: Recently, I was in a meeting at our headquarters in Baltimore, explaining to my editor how excited I was to tell readers about a whole new range of adult stem-cell breakthroughs.

This field of medicine is so exciting it was easy to show how these adult stem cell lines will someday play a vital role in the future of the human race.

Read full article... Read full article...

 


Page << | 1 | 3 | 4 | 5 | 6 | 7 | >>